NCT00897247View on ClinicalTrials.gov

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

CompletedOBSERVATIONAL
Enrollment

494

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2013

Study Completion Date

October 31, 2013

Conditions
Malignant MesotheliomaPulmonary Complications
Interventions
GENETIC

microarray analysis

GENETIC

protein expression analysis

GENETIC

proteomic profiling

OTHER

laboratory biomarker analysis

Trial Locations (1)

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00897247 - Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite | Biotech Hunter | Biotech Hunter